Xeris Pharmaceuticals Inc (XERS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,527 | -11,148 | -9,220 | -54,836 | -49,723 |
| Depreciation Amortization | 12,003 | 7,971 | 3,987 | 15,632 | 11,675 |
| Income taxes - deferred | N/A | N/A | N/A | -2,268 | -2,268 |
| Accounts receivable | -13,336 | -12,633 | -5,915 | -1,218 | -1,941 |
| Accounts payable and accrued liabilities | 1,629 | -367 | 4,062 | -9,613 | -4,410 |
| Other Working Capital | -9,987 | -16,123 | -9,241 | -8,820 | -8,346 |
| Other Operating Activity | 28,801 | 22,451 | 6,296 | 24,142 | 16,057 |
| Operating Cash Flow | $8,583 | $-9,849 | $-10,031 | $-36,981 | $-38,956 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 5,751 | -4,485 |
| PPE Investments | -363 | -292 | -13 | -868 | -648 |
| Investing Cash Flow | $-363 | $-292 | $-13 | $4,883 | $-5,133 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 50,000 | 50,000 |
| Common Stock Issued | 20,991 | 6,663 | 4,861 | 1,733 | 1,169 |
| Common Stock Repurchased | -9,336 | -8,858 | -7,998 | -3,734 | -3,568 |
| Other Financing Activity | 0 | 0 | 0 | -11,831 | -11,831 |
| Financing Cash Flow | $11,655 | $-2,195 | $-3,137 | $36,168 | $35,770 |
| Beginning Cash Position | 75,744 | 75,744 | 75,744 | 71,674 | 71,674 |
| End Cash Position | 95,619 | 63,408 | 62,563 | 75,744 | 63,355 |
| Net Cash Flow | $19,875 | $-12,336 | $-13,181 | $4,070 | $-8,319 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,583 | -9,849 | -10,031 | -36,981 | -38,956 |
| Capital Expenditure | -363 | -292 | -13 | -868 | -648 |
| Free Cash Flow | 8,220 | -10,141 | -10,044 | -37,849 | -39,604 |